pharma · Aplastic Anemia · Advanced Hepatocellular Carcinoma
Kyowa Kirin International
KYOWA KIRIN AUSTRALIA PTY LTD
KYOWA KIRIN AUSTRALIA is a pharma organization headquartered in AU. Primary therapeutic focus areas include Aplastic Anemia, Advanced Hepatocellular Carcinoma, Advanced or Recurrent Breast Cancer, Moderate to Severe Plaq
GB HQ
1995 Founded
690 Employees
TGA registrant Type
Company details
- Status
- Public
- HQ
- GB
- Founded
- 1995
- Employees
- 690
- Programs
- 15
- Drugs
- 12
- Patents
- 0
POTELIGEO 4 mg/mL concentrate for solution for infusion
Phase 2 · small molecule · Mycosis fungoides/Sezary syndrome recurrent
POTELIGEO 4 mg/mL concentrate for solution for infusion for Mycosis fungoides/Sezary syndrome recurrent is a Phase 2 program (small_molecule) at KYOWA KIRIN AUSTRALIA PTY LTD with 1 ClinicalTrials.gov record(s).
Internal code 0761-016
Full intelligence profile for this program is being prepared.
At a glance
- Sponsor
- KYOWA KIRIN AUSTRALIA PTY LTD
- Phase
- Phase 2
- Modality
- small_molecule
- Indication
- Mycosis fungoides/Sezary syndrome recurrent
- Status
- active
- Trials
- 1